相关实验视频
Updated: Jul 16, 2025

05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
5.2K
分析了供体和受体生物标志物与移植功能,功能障碍和排斥之间的关系
Yi-Jie Mao1, Dong-Sheng Xu1, Shuang-De Liu1
1Department of Kidney Transplantation, Multidisciplinary Innovation Center for Nephrology, The Second Hospital of Shandong University, Jinan 250000, China.
Transplant immunology
|September 22, 2023
概括
供体血清TIMP-2和尿液N-乙-b-D-葡萄糖胺酶 (uNAG) 可以预测移植功能的降低. 这些生物标志物为早期检测潜在的移植并发症提供了宝贵的见解.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 移植手术 移植手术
- 生物标志物发现发现
背景情况:
- 移植功能障碍和急性排斥是移植的重大挑战.
- 需要预测性生物标志物来评估捐赠功能,并评估早期拒绝迹象.
研究的目的:
- 确定用于评估捐赠功能的预测生物标志物.
- 预测移植功能障碍和评估急性移植排斥的早期迹象.
主要方法:
- 在27名已故捐赠者和54名接受者中评估了血清和尿液生物标志物,包括中性纤维素凝酶相关的卡林 (NGAL),损伤分子-1 (KIM-1),金属蛋白酶2的组织抑制剂 (TIMP-2) 和尿液N-乙-b-D-葡萄糖胺酶 (uNAG).
- 开发了减少移植功能 (RGF) 的预测模型.
主要成果:
- 供体血清TIMP-2和uNAG水平显示了RGF的预测值 (分别为AUROC 0.714和0.779).
- 捐赠者血清TIMP-2,uNAG和肌素的综合模型在预测RGF时表现优于单独的肌素.
- 受体血清TIMP-2在移植后的第3天强烈预测了第7天的功能 (AUROC 0.99).
结论:
- 供体血清TIMP-2和uNAG是RGF的有价值的预测生物标志物.
- 这些生物标志物使得基于捐赠者的移植结果的预测成为可能.
相关概念视频
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Kidney Transplant II: Surgical Procedure
22
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
22
Tissue Transplantation
391
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
391
Kidney Transplant III: Nursing Management
23
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
23
Bone Marrow Sampling and Transplants
352
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
352

